The dynamics of HER2-low expression during breast cancer progression

被引：0
|
作者：
Sarah Anderson
Brooke Baxter Bartow
Gene P. Siegal
Xiao Huang
Shi Wei
机构：
[1] The University of Alabama at Birmingham,Department of Pathology
[2] The University of Kansas Medical Center,Department of Pathology and Laboratory Medicine
来源：
Breast Cancer Research and Treatment | 2023年 / 201卷
关键词：
Breast cancer; HER2-low; Immunohistochemistry; In situ hybridization; Amplification; Overexpression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：437 / 446
页数：9
相关论文
共 50 条
  • [21] HER2-low breast cancer: where are we?
    Molinelli, Chiara
    Jacobs, Flavia
    Marchio, Caterina
    Pitto, Francesca
    Cosso, Maurizio
    Spinaci, Stefano
    de Azambuja, Evandro
    Schettini, Francesco
    Agostinetto, Elisa
    Lambertini, Matteo
    BREAST CARE, 2022, 17 (06) : 533 - 544
  • [22] Epidemiology of HER2-low breast cancer in Lithuania
    Cesas, A.
    Poskiene, L.
    Valkiuniene, R. B.
    Radvinskiene, L.
    Lege, I.
    EUROPEAN JOURNAL OF CANCER, 2024, 200 : 103 - 104
  • [23] HER2-Low Breast Cancer: a New Subtype?
    Corti, Chiara
    Giugliano, Federica
    Nicolo, Eleonora
    Tarantino, Paolo
    Criscitiello, Carmen
    Curigliano, Giuseppe
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2023, 24 (05) : 468 - 478
  • [24] HER2-Low Breast Cancer: Now and in the Future
    Kang, Sora
    Kim, Sung-Bae
    CANCER RESEARCH AND TREATMENT, 2024, 56 (03): : 700 - 720
  • [25] Computational pathology based HER2 expression quantification in HER2-low breast cancer
    Spitzmueller, Andreas
    Kapil, Ansh
    Shumilov, Anatoliy
    Chan, Jessica
    Konstantinidou, Lemonia
    Hassan, Zonera
    Gustavson, Mark
    Carroll, Danielle
    Della Varghese
    James, Gareth D.
    Moh, Akira
    Livingston, Andrew
    de Giorgio-Miller, Victoria
    CANCER RESEARCH, 2023, 83 (05)
  • [26] A comparison between immunohistochemistry and mRNA expression to detect HER2-low breast cancer
    Navarro, X. Baez
    van Bockstal, M. R.
    van der Made, A.
    van Deurzen, C. H. M.
    EUROPEAN JOURNAL OF CANCER, 2024, 200 : 104 - 104
  • [27] Clinical and Epidemiologic Significance of HER2-Low Expression in Breast Cancer in the Pathways Study
    Khoury, Thaer
    Ondracek, Rochelle Payne
    Yao, Song
    Mendocino, Lucas
    Davis, Warren
    Omilian, Angela
    Kwan, Marilyn
    Roh, Janise
    D'Addario, Lia
    Valice, Emily
    Fernandez, Daniel
    Ergas, Isaac
    Ambrosone, Christine
    Kushi, Lawrence
    CANCER RESEARCH, 2024, 84 (09)
  • [28] Association between HER2-low expression and prognostic clinicopathologic factors in breast cancer
    Akkurt, T. Soylemez
    Gurbuz, B. Calim
    Sen, E.
    HISTOPATHOLOGY, 2022, 81 : 22 - 22
  • [29] Genomic and Transcriptomic Landscape of HER2-Low Breast Cancer
    Bansal, Rani
    McGrath, Julie
    Walker, Phil
    Bustos, Matias A.
    Rodriguez, Estelamari
    Sammons, Sarah L.
    Accordino, Melissa K.
    Meisel, Jane
    Gatti-Mays, Margaret
    Hsu, Emily
    Lathrop, Kate I.
    Kaklamani, Virginia
    Oberley, Matthew
    Korn, W. Michael
    Graff, Stephanie L.
    CANCER RESEARCH, 2023, 83 (05)
  • [30] Comprehensive genomic characterization of HER2-low breast cancer
    Tarantino, Paolo
    Gupta, Hersh V.
    Hughes, Melissa E.
    Files, Janet L.
    Strauss, Sarah
    Kirkner, Gregory
    Feeney, Anne-Marie
    Li, Yvonne Y.
    Garrido-Castro, Ana C.
    Barroso-Sousa, Romualdo
    Bychkovsky, Brittany
    MacConaill, Laura
    Lindeman, Neal
    Johnson, Bruce
    Meyerson, Matthew
    Kabraji, Sheheryar
    Jeselsohn, Rinath
    Qiu, Xintao
    Li, Rong
    Long, Henry W.
    Winer, Eric
    Dillon, Deborah A.
    Curigliano, Giuseppe
    Cherniack, Andrew
    Tolaney, Sara
    Lin, Nancy U.
    CANCER RESEARCH, 2023, 83 (05)
12345